Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00679341 |
|---|---|
| Brief Title: | A Study of the Efficacy and Safety of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) vs. Trastuzumab (Herceptin®) and Docetaxel (Taxotere®) in Patients With Metastatic HER2-positive Breast Cancer Who Have Not Received Prior Chemotherapy for Metastatic Disease |
| First Submitted : | May 14, 2008 |
| First Submitted that Met QC Criteria : | May 14, 2008 |
| First Posted : | May 16, 2008 (Estimate) |
| Results First Submitted : | February 22, 2013 |
| Results First Submitted that Met QC Criteria : | April 10, 2013 |
| Results First Posted : | May 20, 2013 (Estimate) |
| Last Update Submitted that Met QC Criteria : | December 9, 2013 |
| Last Update Posted : | January 9, 2014 (Estimate) |